Skip to content

reSET® 1

by Pear Therapeutics, Inc. 2 variants

reSET 1 is a mental health/function therapeutic software (FDA Class II; FDA product code PWE, Computerized Behavioral Therapy Device For Psychiatric Disorders) made by Pear Therapeutics, Inc., granted FDA De Novo DEN160018 on 14 Sep 2017 and listed in FDA GUDID since 15 Jul 2019 (UDI-DI 10851580008071), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

De Novo DEN160018

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number10851580008071 UDI-DI Date15 Jul 2019ListedStatusListed GUDID: in commercial distribution
United StatesFDA De NovoDENG from GUDID De Novo granted · Direct NumberDEN160018 Date14 Sep 2017DecidedStatusActive

Official records

From the FDA record

Device description
reSET® is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12 week (90 days) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to: - increase abstinence from a patient’s substances of abuse during treatment, and - increase retention in the outpatient treatment program.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA De Novo DEN160018 decided 14 Sep 2017 Active
  • FDA GUDID UDI-DI 10851580008071 listed 15 Jul 2019 Listed

Timeline

2 dated events

  1. Granted FDA De Novo DEN160018
  2. Listed FDA GUDID 10851580008071

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

GUDID

Trade name
reSET®
Generic name
Mental health/function therapeutic software, screen-viewed
Model / reference
1
Primary DI / UDI-DI
10851580008071
De Novo Number
FDA product code
PWE
GMDN term
Mental health/function therapeutic software, screen-viewed
Device class
Class II
Regulation number
882.5801
GUDID distribution status
In Commercial Distribution

Other devices from Pear Therapeutics, Inc.

See all devices from Pear Therapeutics, Inc. →

Properties

  • Prescription use
  • Lot / batch number
Other properties (13, all answered No)